Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer

Author:                  

Publisher: Spandidos Publications

E-ISSN: 1791-2431|34|5|2319-2324

ISSN: 1021-335X

Source: Oncology Reports, Vol.34, Iss.5, 2015-01, pp. : 2319-2324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content